Larimar Therapeutics, Inc.(LRMR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LRMR Larimar Therapeutics, Inc.

休市中 08-07 16:00:00 EDT

4.16

-0.04

-0.95%

盘后4.08

-0.08-1.92%

19:34 EDT

最高4.28	最低4.08	成交量63.12万
今开4.24	昨收4.20	日振幅4.76%
总市值4.33亿	流通市值2.47亿	总股本1.04亿
成交额261.92万	换手率1.06%	流通股本5,949万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LRMR","market":"US","secType":"STK","nameCN":"Larimar Therapeutics, Inc.","latestPrice":4.16,"timestamp":1786132800000,"preClose":4.2,"halted":0,"volume":631188,"hourTrading":{"tag":"盘后","latestPrice":4.08,"preClose":4.16,"latestTime":"19:34 EDT","volume":3398,"amount":14111.2,"timestamp":1786145648177,"change":-0.08,"changeRate":-0.019231,"amplitude":0.019231},"delay":0,"changeRate":-0.009523809523809532,"floatShares":59489900,"shares":104000000,"eps":-1.925766,"marketStatus":"休市中","change":-0.04,"latestTime":"08-07 16:00:00 EDT","open":4.24,"high":4.28,"low":4.08,"amount":2619202.1517756,"amplitude":0.047619,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.925766,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1786348800000},"marketStatusCode":7,"adr":0,"listingDate":1403150400000,"exchange":"NASDAQ","adjPreClose":4.2,"preHourTrading":{"tag":"盘前","latestPrice":4.2,"preClose":4.2,"latestTime":"06:23 EDT","volume":4,"amount":16.8,"timestamp":1786098188004,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.08,"preClose":4.16,"latestTime":"19:34 EDT","volume":3398,"amount":14111.2,"timestamp":1786145648177,"change":-0.08,"changeRate":-0.019231,"amplitude":0.019231},"volumeRatio":0.5660418982335736,"impliedVol":2.6048,"impliedVolPercentile":0.7052},"requestUrl":"/m/hq/s/LRMR","defaultTab":"news","newsList":[{"id":"1101436306","title":"Larimar公司Nomlabofusp长期给药总体耐受性良好；43名患者中10例出现过敏反应","url":"https://stock-news.laohu8.com/highlight/detail?id=1101436306","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101436306?lang=zh_cn&edition=full","pubTime":"2026-06-29 18:32","pubTimestamp":1782729142,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics公布的数据显示，其药物Nomlabofusp的长期给药方案在总体上表现出良好的耐受性。然而，在参与研究的43名患者中，有10例出现了过敏反应。这一发现凸显了在评估该疗法安全性时需持续关注的风险因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174428798","title":"Larimar Therapeutics提交首个滚动生物制剂许可申请模块，其余部分预计2026年下半年完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1174428798","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174428798?lang=zh_cn&edition=full","pubTime":"2026-06-29 18:32","pubTimestamp":1782729136,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics公司已提交了其候选药物nomlabofusp滚动生物制剂许可申请（BLA）的首个模块。该公司预计，申请所需的其余模块将在2026年下半年完成提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LRMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109253702","title":"Larimar Therapeutics计划于2026年6月提交BLA申请，目标2027年上半年在美国上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1109253702","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109253702?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:09","pubTimestamp":1773918554,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics, Inc. 已为其核心候选产品制定了明确的监管审批与商业化时间表。公司计划在2026年6月向美国食品药品监督管理局（FDA）提交生物制品许可申请（BLA）。若审批进程顺利，该疗法预计将于2027年上半年在美国市场正式推出。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142027163","title":"Larimar Therapeutics宣布启动7500万美元承销公开发行计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1142027163","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142027163?lang=zh_cn&edition=full","pubTime":"2026-02-26 05:03","pubTimestamp":1772053395,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Larimar Therapeutics, Inc.于2026年2月25日披露，正式启动规模达7500万美元的普通股承销公开发行。部分投资者可选择以预融资权证替代普通股进行认购。该公司同时授予承销商30天超额配售选择权，可按发行价额外认购至多1125万美元的证券。本次发行所有普通股及预融资权证均由Larimar Therapeutics直接出售，最终完成与否将取决于市场环境及其他条件，实际发行规模与条款可能存在变数。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","BK4139","LENZ","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513733657","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513733657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513733657?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:38","pubTimestamp":1740411516,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时38分，Larimar Therapeutics, Inc.股票出现波动，股价大幅下挫5.02%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233836962ea893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233836962ea893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512667111","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大涨5.39%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512667111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512667111?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:50","pubTimestamp":1739890228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时50分，Larimar Therapeutics, Inc.股票出现异动，股价急速拉升5.39%。截至发稿，该股报3.52美元/股，成交量5.0239万股，换手率0.08%，振幅4.94%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225028abd3b3a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225028abd3b3a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508450756","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大涨5.01%报3.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508450756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508450756?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:03","pubTimestamp":1738681407,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时03分，Larimar Therapeutics, Inc.股票出现异动，股价急速上涨5.01%。截至发稿，该股报3.73美元/股，成交量3.8992万股，换手率0.06%，振幅4.23%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042303279617dd04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042303279617dd04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507463516","title":"Larimar Therapeutics(LRMR.US)获Truist Securities首次覆盖，给予买入评级, 目标价18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507463516","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507463516?lang=zh_cn&edition=full","pubTime":"2025-01-29 21:35","pubTimestamp":1738157713,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics(LRMR.US)获Truist Securities首次覆盖，给予买入评级, 目标价18.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29213547898192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503864263","title":"Larimar Therapeutics, Inc.盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503864263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503864263?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951537,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Larimar Therapeutics, Inc.股票出现异动，股价急速上涨5.47%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.06%、52.88%、35.43%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为14.29%、12.00%、10.72%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232189604b414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232189604b414&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LRMR","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503830295","title":"Larimar Therapeutics, Inc.盘中异动 早盘急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503830295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503830295?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:36","pubTimestamp":1736779004,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时36分，Larimar Therapeutics, Inc.股票出现波动，股价急速下挫5.08%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.99%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3523.95%、2133.17%、393.34%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、61.54%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223644a22040e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223644a22040e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500240111","title":"Larimar Therapeutics, Inc.盘中异动 早盘大幅上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500240111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500240111?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:36","pubTimestamp":1735914997,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时36分，Larimar Therapeutics, Inc.股票出现异动，股价大幅拉升5.24%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223637a2146a2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223637a2146a2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491134694","title":"Larimar Therapeutics, Inc.盘中异动 大幅跳水36.14%报3.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491134694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491134694?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359476,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分，Larimar Therapeutics, Inc.股票出现异动，股价大幅下跌36.14%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490801276","title":"Larimar Therapeutics, Inc.盘中异动 早盘大幅下跌5.33%报6.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490801276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490801276?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:31","pubTimestamp":1733844668,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时31分，Larimar Therapeutics, Inc.股票出现波动，股价急速下跌5.33%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1918.05%、439.66%、125.47%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Uniqure N.V.，振幅分别为154.91%、131.78%、42.77%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023310895e8b152&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023310895e8b152&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LRMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486503832","title":"Larimar Therapeutics, Inc.盘中异动 早盘大幅拉升5.03%报6.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486503832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486503832?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:40","pubTimestamp":1732545653,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时40分，Larimar Therapeutics, Inc.股票出现波动，股价急速拉升5.03%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224053a25491e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224053a25491e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LRMR","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2480691581","title":"Larimar Therapeutics, Inc.盘中异动 大幅下挫5.43%报7.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480691581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2480691581?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:37","pubTimestamp":1730731034,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时37分，Larimar Therapeutics, Inc.股票出现异动，股价快速跳水5.43%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223714a2154b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223714a2154b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2480885806","title":"Larimar Therapeutics, Inc.盘中异动 下午盘股价大跌5.17%报7.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480885806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2480885806?lang=zh_cn&edition=full","pubTime":"2024-11-02 01:58","pubTimestamp":1730483938,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日01时58分，Larimar Therapeutics, Inc.股票出现波动，股价急速下挫5.17%。截至发稿，该股报7.80美元/股，成交量16.0319万股，换手率0.25%，振幅6.57%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201585898e40113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201585898e40113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479783790","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479783790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2479783790?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:32","pubTimestamp":1730295123,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时32分，Larimar Therapeutics, Inc.股票出现波动，股价快速拉升5.40%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1767.79%、99.22%、15.91%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Cormedix Inc.，振幅分别为27.09%、11.49%、11.41%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021320395bd8e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021320395bd8e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LRMR","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2478722486","title":"Larimar Therapeutics, Inc.盘中异动 股价大涨5.62%报8.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478722486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2478722486?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:46","pubTimestamp":1730123165,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时46分，Larimar Therapeutics, Inc.股票出现异动，股价快速上涨5.62%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214606a1f2552f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214606a1f2552f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2478650446","title":"Larimar Therapeutics, Inc.盘中异动 下午盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478650446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2478650446?lang=zh_cn&edition=full","pubTime":"2024-10-25 01:54","pubTimestamp":1729792473,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日01时54分，Larimar Therapeutics, Inc.股票出现波动，股价急速上涨5.03%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025015433971a21fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025015433971a21fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2472178619","title":"Larimar Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472178619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2472178619?lang=zh_cn&edition=full","pubTime":"2024-10-03 21:45","pubTimestamp":1727963125,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日21时45分，Larimar Therapeutics, Inc.股票出现异动，股价急速拉升5.01%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003214525ab6798d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003214525ab6798d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LRMR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.larimartx.com","stockEarnings":[{"period":"1week","weight":0.089},{"period":"1month","weight":0.1524},{"period":"3month","weight":0.0479},{"period":"6month","weight":0.2344},{"period":"1year","weight":0.1366},{"period":"ytd","weight":0.0919}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1197},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.1339}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Larimar Therapeutics, Inc.，于2005年11月22日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，专注于利用公司新型细胞穿透肽（“CPP”）技术平台为患有复杂罕见疾病的患者开发治疗方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.088036},{"month":2,"riseRate":0.583333,"avgChangeRate":0.090114},{"month":3,"riseRate":0.25,"avgChangeRate":-0.145723},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.03405},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.096181},{"month":6,"riseRate":0.5,"avgChangeRate":-0.004489},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.000858},{"month":8,"riseRate":0.538462,"avgChangeRate":0.081961},{"month":9,"riseRate":0.416667,"avgChangeRate":0.000938},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.029427},{"month":11,"riseRate":0.583333,"avgChangeRate":0.038429},{"month":12,"riseRate":0.583333,"avgChangeRate":0.050649}],"exchange":"NASDAQ","name":"Larimar Therapeutics, Inc.","nameEN":"Larimar Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Larimar Therapeutics, Inc.(LRMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Larimar Therapeutics, Inc.(LRMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Larimar Therapeutics, Inc.,LRMR,Larimar Therapeutics, Inc.股票,Larimar Therapeutics, Inc.股票老虎,Larimar Therapeutics, Inc.股票老虎国际,Larimar Therapeutics, Inc.行情,Larimar Therapeutics, Inc.股票行情,Larimar Therapeutics, Inc.股价,Larimar Therapeutics, Inc.股市,Larimar Therapeutics, Inc.股票价格,Larimar Therapeutics, Inc.股票交易,Larimar Therapeutics, Inc.股票购买,Larimar Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Larimar Therapeutics, Inc.(LRMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Larimar Therapeutics, Inc.(LRMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}